We are live on ! Find out more
LRMR icon

Larimar Therapeutics
LRMR

93 hedge funds and large institutions have $880M invested in Larimar Therapeutics in 2015 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 9

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

83% more capital invested

Capital invested by funds: $481M → $880M (+$398M)

60% more funds holding

Funds holding: 58 → 93 (+35)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
93
Holders Change
+35
Holders Change %
+60.34%
% of All Funds
2.48%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
44
Increased
32
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FCMI
Foresite Capital Management II
California
+$119M
2
DM
Deerfield Management
New York
+$41.5M
3
JHIU
Janus Henderson Investors US
Colorado
+$31.2M
4
Jennison Associates
Jennison Associates
New York
+$26.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.1M

Top Sellers

1
TRV
Third Rock Ventures
Massachusetts
-$55.4M
2
PA
Perceptive Advisors
New York
-$8.58M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.81M
4
SFM
Sphera Funds Management
Israel
-$2.22M
5
Principal Financial Group
Principal Financial Group
Iowa
-$1.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRV
1
Third Rock Ventures
Massachusetts
$166M -$55.4M -116,667 -25%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$155M +$20.3M +42,851 +15%
FCMI
3
Foresite Capital Management II
California
$56.5M +$119M +250,940 +602%
DM
4
Deerfield Management
New York
$41.6M +$41.5M +87,515 New
Jennison Associates
5
Jennison Associates
New York
$37.8M +$26.2M +55,130 +227%
JHIU
6
Janus Henderson Investors US
Colorado
$31.3M +$31.2M +65,764 New
Franklin Resources
7
Franklin Resources
California
$30.9M +$1.72M +3,626 +6%
RCM
8
RA Capital Management
Massachusetts
$29M – – –
BCPEM
9
Bain Capital Public Equity Management
Massachusetts
$26.4M – – –
Capital World Investors
10
Capital World Investors
California
$24M +$16.2M +34,229 +211%
State Street
11
State Street
Massachusetts
$23.4M +$20.8M +43,827 +815%
BFA
12
BlackRock Fund Advisors
California
$21.8M +$3.67M +7,737 +20%
VM
13
VHCP Management
New York
$21.4M – – –
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$21.1M +$21.1M +44,380 New
Wellington Management Group
15
Wellington Management Group
Massachusetts
$20.7M +$963K +2,029 +5%
Vanguard Group
16
Vanguard Group
Pennsylvania
$14.5M +$6.41M +13,499 +79%
GIM
17
Granahan Investment Management
Massachusetts
$13M +$8.69M +18,300 +203%
Loomis, Sayles & Company
18
Loomis, Sayles & Company
Massachusetts
$12.9M +$12.9M +27,103 New
RIM
19
RS Investment Management
California
$12.5M +$12.5M +26,341 New
VAM
20
Visium Asset Management
New York
$8.85M +$8.84M +18,618 New
BA
21
BlackRock Advisors
Delaware
$7.83M +$7.71M +16,245 +7,351%
PC
22
Pier Capital
Connecticut
$6.67M +$6.66M +14,032 New
LOAMU
23
Lombard Odier Asset Management (USA)
New York
$5.47M +$1.18M +2,495 +28%
FCM
24
Farallon Capital Management
California
$5.15M +$2.77M +5,833 +117%
BIT
25
BlackRock Institutional Trust
California
$4.98M +$2.58M +5,439 +108%
1
2 3 4 5

LRMR Hedge Fund Activity: Q1 2015 in Review

93 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Larimar Therapeutics (LRMR) for Q1 2015, worth a combined $880M — up 83% from $481M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new LRMR positions and 9 closed out — a net gain of 35 holders — while 32 added to existing stakes and 12 trimmed.

The largest buyer was Foresite Capital Management II, adding an estimated $119M. The largest seller was Third Rock Ventures, cutting an estimated $55.4M.

  • 93 institutional investors held Larimar Therapeutics (LRMR) as of Q1 2015, up from 58 in Q4 2014.
  • Funds reported $880M of Larimar Therapeutics stock for Q1 2015, up 83% quarter-over-quarter.
  • 44 funds opened new Larimar Therapeutics positions in Q1 2015 and 9 closed out, a net change of +35 holders.
  • The largest Larimar Therapeutics buyer in Q1 2015 was Foresite Capital Management II, an estimated $119M added.
  • The largest Larimar Therapeutics seller in Q1 2015 was Third Rock Ventures, an estimated $55.4M sold.

Based on aggregated 13F filings for Q1 2015.